• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    DF/HCC and Northeastern University work together to offer training opportunities in cancer nanomedicine

    August 19, 2014

    Northeastern University has received a five-year, $1.15 million grant from the National Institute of Health’s National Cancer Institute to train the next generation of cancer nanomedicine scientists and clinicians through a unique experiential learning program. 

    The grant aligns with Northeastern’s focus on discovering solutions to global challenges in health, one of the university’s three programmatic pillars. 

    “Nanotechnology is leading to breakthroughs in diagnosis and therapy of many diseases, particularly cancer, leading to the new discipline of cancer nanomedicine,” said principal investigator Srinivas Sridhar, Northeastern’s Arts and Science Distinguished Professor of Physics, Bioengineering, and Chemical Engineering, and the director of the university’s IGERT Nanomedicine Science and Technology program

    Sorensen awarded NCI funding to study tobacco cessation intervention in India

    Glorian Sorensen PhD, MPH (DFCI) was recently awarded $200,000 from the National Cancer Institute (NCI) to promote research collaborations with institutions in low- and mid-income countries (LMICs)

    NCI Center to Reduce Cancer Health Disparities Spotlights Center for Personalized Cancer Therapy

    UMass Boston and DF/HCC have a U54 Partnership grant with NCI/CRCHD to develop life sciences and CPCT on the UMass Boston campus. Read the Spotlight: http://crchd.cancer.gov/news/spotlights/grantee-spotlights_macoska.html 

     

     

     

     

     

    DF/HCC Members Presented with 2014 AACR Awards

    April 14, 2014

    Congratulations to Levi Garraway and Rakesh Jain, who were among the 2014 American Association for Cancer Research (AACR) awardees:

    Levi Garraway (DFCI) was awarded the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship for his research in the field of cancer genomics and functional approaches to characterize solid tumors, especially melanoma and prostate cancer

    Bromodomain Inhibition: Helping Cancer Cells “Forget”

    April 2014 | eNews

    The TPETT program, with its mission to facilitate the development of new anticancer agents from the preclinical to the clinical stages, relies on basic research to provide new compounds for study

    DF/HCC TPETT Program: Testing novel therapeutics in phase I and II trials

    April 2014 | eNews

    As researchers delve ever deeper into the underpinnings of cancer biology, more therapeutic targets emerge; targets that, when attacked, will in theory shut down the growth of cancer cells—ideally while sparing healthy cells

    High-Throughput Polymorphism Detection

    April 2014 | eNews

    The DF/HCC High-Throughput Polymorphism Detection Core provides services to Cancer Center members conducting molecular analyses of germline and somatic DNA collected as part of a wide range of investigations into the molecular epidemiology of cancer, including Genome Wide Association Studies (GWAS)

Displaying results 1 to 7 out of 208
<< First < Previous 1-7 8-14 15-21 22-28 29-35 36-42 43-49 Next > Last >>